APP and Alzheimer disease: In hypercholesterolemic AD model APP/PS1/SREBP-2 transgenic mice, the amount and toxic effects of Aβ42 including tau pathology, oxidative damage, and neuroinflammation, were increased compared with APP/PS1 mice with normal cholesterol levels (Barbero-Camps et al., 2013).